Molina Healthcare
619 hedge funds and large institutions have $17.7B invested in Molina Healthcare in 2025 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 208 increasing their positions, 245 reducing their positions, and 89 closing their positions.
38% more call options, than puts
Call options by funds: $59.9M | Put options by funds: $43.6M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
14% more capital invested
Capital invested by funds: $15.5B → $17.7B (+$2.21B)
5.24% more ownership
Funds ownership: 93.17% → 98.41% (+5.2%)
6% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 89
2% less funds holding
Funds holding: 633 → 619 (-14)
15% less repeat investments, than reductions
Existing positions increased: 208 | Existing positions reduced: 245
Top Buyers
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$178M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$123M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$115M |
| 4 |
BlackRock
New York
|
-$58.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$48.1M |
MOH Hedge Fund Activity: Q1 2025 in Review
619 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Molina Healthcare (MOH) for Q1 2025, worth a combined $17.7B — up 14% from $15.5B a quarter earlier.
Sellers outnumbered buyers: 89 funds closed out of MOH and 84 opened new positions — a net loss of 5 holders — while 245 trimmed existing stakes and 208 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $368M. The largest seller was Capital Research Global Investors, cutting an estimated $178M.
- 619 institutional investors held Molina Healthcare (MOH) as of Q1 2025, down from 633 in Q4 2024.
- Funds reported $17.7B of Molina Healthcare stock for Q1 2025, up 14% quarter-over-quarter.
- 84 funds opened new Molina Healthcare positions in Q1 2025 and 89 closed out, a net change of -5 holders.
- The largest Molina Healthcare buyer in Q1 2025 was T. Rowe Price Associates, an estimated $368M added.
- The largest Molina Healthcare seller in Q1 2025 was Capital Research Global Investors, an estimated $178M sold.
Based on aggregated 13F filings for Q1 2025.